| (+)-pilocarpine | increases expression | ISO | RGD:1550017 | 6480464 | Pilocarpine results in increased expression of PRKCB protein | CTD | PMID:18774262 |
| (+)-pilocarpine | decreases expression | EXP | | 6480464 | Pilocarpine results in decreased expression of PRKCB mRNA | CTD | PMID:17971868 |
| (+)-pilocarpine | increases expression | EXP | | 6480464 | Pilocarpine results in increased expression of PRKCB protein | CTD | PMID:15058486 |
| (S)-nicotine | affects localization | ISO | RGD:731404 | 6480464 | Nicotine affects the localization of PRKCB protein | CTD | PMID:17003101 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of PRKCB mRNA | CTD | PMID:17351261 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of PRKCB mRNA | CTD | PMID:20068009 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731404 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PRKCB mRNA | CTD | PMID:19684285 PMID:11007951 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1550017 | 6480464 | PRKCB protein inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] | CTD | PMID:10037446 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PRKCB mRNA | CTD | PMID:20959002 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731404 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PRKCB mRNA | CTD | PMID:11007951 PMID:19684285 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects localization | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the localization of PRKCB protein | CTD | PMID:16797713 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases localization | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased localization of PRKCB protein | CTD | PMID:17222441 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of PRKCB protein] | CTD | PMID:17222441 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of PRKCB protein]; more ... | CTD | PMID:16797713 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1550017 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PRKCB mRNA | CTD | PMID:19465110 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731404 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of PRKCB mRNA | CTD | PMID:19684285 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of PRKCB mRNA | CTD | PMID:21346803 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1550017 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PRKCB mRNA | CTD | PMID:19285098 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1550017 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PRKCB mRNA | CTD | PMID:19285098 PMID:20188158 |
| 3-chloropropane-1,2-diol | decreases expression | EXP | | 6480464 | alpha-Chlorohydrin results in decreased expression of PRKCB mRNA | CTD | PMID:20409345 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of PRKCB mRNA | CTD | PMID:19162173 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:1550017 | 6480464 | PRKCB protein inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; more ... | CTD | PMID:10037446 |
| acetaldehyde | multiple interactions | ISO | RGD:731404 | 6480464 | PRKCB protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin]]; more ... | CTD | PMID:17991733 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:731404 | 6480464 | Aspirin inhibits the reaction [Deoxycholic Acid results in increased expression of PRKCB protein] | CTD | PMID:17644113 |
| acetylsalicylic acid | affects expression | ISO | RGD:731404 | 6480464 | Aspirin affects the expression of PRKCB protein | CTD | PMID:17644113 |
| all-trans-retinoic acid | increases expression | ISO | RGD:731404 | 6480464 | Tretinoin results in increased expression of PRKCB mRNA | CTD | PMID:16054129 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:731404 | 6480464 | Tretinoin promotes the reaction [arsenic trioxide results in increased expression of PRKCB mRNA] | CTD | PMID:10673743 |
| all-trans-retinoic acid | increases expression | ISO | RGD:731404 | 6480464 | Tretinoin results in increased expression of PRKCB mRNA | CTD | PMID:15498508 PMID:16054129 |
| all-trans-retinoic acid | increases expression | ISO | RGD:731404 | 6480464 | Tretinoin results in increased expression of PRKCB mRNA | CTD | PMID:16054129 PMID:15498508 |
| all-trans-retinoic acid | increases phosphorylation | ISO | RGD:731404 | 6480464 | Tretinoin results in increased phosphorylation of PRKCB protein | CTD | PMID:19476501 |
| all-trans-retinoic acid | increases phosphorylation | ISO | RGD:1550017 | 6480464 | Tretinoin results in increased phosphorylation of PRKCB protein | CTD | PMID:19476501 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PRKCB mRNA | CTD | PMID:16483693 |
| ammonium chloride | decreases expression | EXP | | 6480464 | Ammonium Chloride results in decreased expression of PRKCB protein | CTD | PMID:16483693 |
| amphetamine | affects expression | EXP | | 6480464 | Amphetamine affects the expression of PRKCB mRNA | CTD | PMID:16101753 |
| arsenite(3-) | decreases expression | ISO | RGD:1550017 | 6480464 | arsenite results in decreased expression of PRKCB mRNA | CTD | PMID:18191166 |
| benzo[a]pyrene | decreases expression | ISO | RGD:731404 | 6480464 | Benzo(a)pyrene results in decreased expression of PRKCB mRNA | CTD | PMID:20064835 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1550017 | 6480464 | Benzo(a)pyrene results in decreased expression of PRKCB mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1550017 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of PRKCB mRNA | CTD | PMID:21715664 |
| bis(2-chloroethyl) sulfide | decreases expression | ISO | RGD:1550017 | 6480464 | Mustard Gas results in decreased expression of PRKCB mRNA | CTD | PMID:15674843 |
| bupivacaine | multiple interactions | EXP | | 6480464 | [Bupivacaine co-treated with Tetrodotoxin co-treated with Dexamethasone] results in decreased expression of PRKCB mRNA | CTD | PMID:22341215 |
| butan-1-ol | affects localization | ISO | RGD:731404 | 6480464 | 1-Butanol affects the localization of PRKCB protein | CTD | PMID:15067001 |
| calcium atom | multiple interactions | ISO | RGD:1550017 | 6480464 | Calcium inhibits the reaction [Chlordecone results in increased activity of PRKCB protein]; more ... | CTD | PMID:1724372 |
| calcium(0) | multiple interactions | ISO | RGD:1550017 | 6480464 | Calcium inhibits the reaction [Chlordecone results in increased activity of PRKCB protein]; more ... | CTD | PMID:1724372 |
| chlordecone | multiple interactions | ISO | RGD:1550017 | 6480464 | Calcium inhibits the reaction [Chlordecone results in increased activity of PRKCB protein]; more ... | CTD | PMID:1724372 |
| chlordecone | increases activity | ISO | RGD:1550017 | 6480464 | Chlordecone results in increased activity of PRKCB protein | CTD | PMID:1724372 |
| chloroprene | decreases expression | ISO | RGD:1550017 | 6480464 | Chloroprene results in decreased expression of PRKCB mRNA | CTD | PMID:23125180 |
| chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of PRKCB mRNA | CTD | PMID:19368821 |
| choline | affects expression | EXP | | 6480464 | Choline affects the expression of PRKCB mRNA; more ... | CTD | PMID:17264169 |
| choline | multiple interactions | ISO | RGD:1550017 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of PRKCB; more ... | CTD | PMID:20938992 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of PRKCB mRNA | CTD | PMID:22023808 |
| clozapine | affects expression | EXP | | 6480464 | Clozapine affects the expression of PRKCB protein | CTD | PMID:15967061 |
| clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of PRKCB mRNA | CTD | PMID:15860345 |
| cobalt dichloride | multiple interactions | EXP | | 6480464 | cobaltous chloride results in increased oxidation of and results in increased activity of PRKCB protein | CTD | PMID:18375950 |
| cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of PRKCB mRNA | CTD | PMID:17898221 |
| cocaine | decreases expression | ISO | RGD:731404 | 6480464 | Cocaine results in decreased expression of PRKCB mRNA | CTD | PMID:12629581 |
| cycloheximide | decreases expression | ISO | RGD:731404 | 6480464 | Cycloheximide results in decreased expression of PRKCB mRNA | CTD | PMID:19684285 |
| cycloheximide | multiple interactions | ISO | RGD:731404 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of PRKCB mRNA | CTD | PMID:19684285 |
| cyclosporin A | increases expression | ISO | RGD:1550017 | 6480464 | Cyclosporine results in increased expression of PRKCB protein | CTD | PMID:22155090 |
| D-glucose | multiple interactions | EXP | | 6480464 | PRKCB protein affects the reaction [Glucose results in increased activity of RELA protein]; more ... | CTD | PMID:19587355 |
| D-glucose | increases phosphorylation | ISO | RGD:731404 | 6480464 | Glucose results in increased phosphorylation of PRKCB protein | CTD | PMID:22162761 |
| D-glucose | multiple interactions | ISO | RGD:731404 | 6480464 | resveratrol inhibits the reaction [Glucose results in increased activity of PRKCB protein] | CTD | PMID:20578705 |
| D-glucose | increases activity | ISO | RGD:731404 | 6480464 | Glucose results in increased activity of PRKCB protein | CTD | PMID:20578705 |
| daidzein | increases activity | EXP | | 6480464 | daidzein results in increased activity of PRKCB protein | CTD | PMID:16972265 |
| deoxycholic acid | multiple interactions | ISO | RGD:731404 | 6480464 | Aspirin inhibits the reaction [Deoxycholic Acid results in increased expression of PRKCB protein]; more ... | CTD | PMID:17644113 |
| deoxycholic acid | increases expression | ISO | RGD:731404 | 6480464 | Deoxycholic Acid results in increased expression of PRKCB protein | CTD | PMID:17644113 |
| dexamethasone | multiple interactions | EXP | | 6480464 | [Bupivacaine co-treated with Tetrodotoxin co-treated with Dexamethasone] results in decreased expression of PRKCB mRNA | CTD | PMID:22341215 |
| diarsenic trioxide | decreases expression | ISO | RGD:731404 | 6480464 | arsenic trioxide results in decreased expression of PRKCB mRNA | CTD | PMID:15725085 |
| diarsenic trioxide | multiple interactions | ISO | RGD:731404 | 6480464 | Tretinoin promotes the reaction [arsenic trioxide results in increased expression of PRKCB mRNA] | CTD | PMID:10673743 |
| diarsenic trioxide | increases expression | ISO | RGD:731404 | 6480464 | arsenic trioxide results in increased expression of PRKCB mRNA | CTD | PMID:10673743 |
| diazoxide | decreases expression | ISO | RGD:1550017 | 6480464 | Isoproterenol results in decreased expression of PRKCB mRNA | CTD | PMID:21335049 |
| dicofol | multiple interactions | ISO | RGD:1550017 | 6480464 | Calcium inhibits the reaction [Dicofol results in increased activity of PRKCB protein]; more ... | CTD | PMID:1724372 |
| dicofol | increases activity | ISO | RGD:1550017 | 6480464 | Dicofol results in increased activity of PRKCB protein | CTD | PMID:1724372 |
| diethylstilbestrol | increases expression | ISO | RGD:1550017 | 6480464 | Diethylstilbestrol results in increased expression of PRKCB mRNA | CTD | PMID:16636312 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of PRKCB mRNA | CTD | PMID:17005392 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of PRKCB mRNA | CTD | PMID:21551480 |
| elemental selenium | decreases expression | ISO | RGD:731404 | 6480464 | Selenium results in decreased expression of PRKCB mRNA | CTD | PMID:19244175 |
| ethanol | multiple interactions | ISO | RGD:731404 | 6480464 | [Ethanol results in increased localization of and results in increased activity of PRKCB protein] promotes the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Superoxides] | CTD | PMID:10651808 |
| ethanol | multiple interactions | ISO | RGD:1550017 | 6480464 | Ethanol results in increased expression of and results in increased activity of PRKCB protein | CTD | PMID:22497828 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of PRKCB protein | CTD | PMID:22497828 |
| ethanol | multiple interactions | EXP | | 6480464 | PRKCB protein affects the reaction [Ethanol results in increased cleavage of and results in increased activity of CASP3 protein]; more ... | CTD | PMID:22497828 |
| fluvoxamine | multiple interactions | EXP | | 6480464 | [Haloperidol co-treated with Fluvoxamine] affects the expression of PRKCB protein | CTD | PMID:15967061 |
| folic acid | multiple interactions | ISO | RGD:1550017 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRKCB gene; more ... | CTD | PMID:20938992 |
| furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of PRKCB mRNA | CTD | PMID:15120968 |
| furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of PRKCB gene | CTD | PMID:22079235 |
| glucose | multiple interactions | EXP | | 6480464 | PRKCB protein affects the reaction [Glucose results in increased activity of RELA protein]; more ... | CTD | PMID:19587355 |
| glucose | increases phosphorylation | ISO | RGD:731404 | 6480464 | Glucose results in increased phosphorylation of PRKCB protein | CTD | PMID:22162761 |
| glucose | increases activity | ISO | RGD:731404 | 6480464 | Glucose results in increased activity of PRKCB protein | CTD | PMID:20578705 |
| glucose | multiple interactions | ISO | RGD:731404 | 6480464 | resveratrol inhibits the reaction [Glucose results in increased activity of PRKCB protein] | CTD | PMID:20578705 |
| haloperidol | multiple interactions | EXP | | 6480464 | [Haloperidol co-treated with Fluvoxamine] affects the expression of PRKCB protein | CTD | PMID:15967061 |
| haloperidol | increases expression | EXP | | 6480464 | Haloperidol results in increased expression of PRKCB mRNA | CTD | PMID:15860345 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | Hydrogen Peroxide affects the localization of and results in increased activity of PRKCB protein | CTD | PMID:12821678 |
| indomethacin | decreases expression | ISO | RGD:731404 | 6480464 | Indomethacin results in decreased expression of PRKCB protein alternative form | CTD | PMID:10702201 |
| indomethacin | decreases response to substance | ISO | RGD:731404 | 6480464 | PRKCB protein alternative form results in decreased susceptibility to Indomethacin | CTD | PMID:10702201 |
| indomethacin | increases expression | ISO | RGD:731404 | 6480464 | Indomethacin results in increased expression of PRKCB protein alternative form | CTD | PMID:10702201 |
| inulin | multiple interactions | ISO | RGD:731404 | 6480464 | PRKCB protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde results in increased transport of Inulin]] | CTD | PMID:17991733 |
| isoprenaline | decreases expression | ISO | RGD:1550017 | 6480464 | Isoproterenol results in decreased expression of PRKCB mRNA | CTD | PMID:21335049 |
| L-ascorbic acid | increases expression | ISO | RGD:1550017 | 6480464 | Ascorbic Acid results in increased expression of PRKCB mRNA | CTD | PMID:15305145 |
| L-methionine | multiple interactions | ISO | RGD:1550017 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRKCB gene; more ... | CTD | PMID:20938992 |
| lactacystin | multiple interactions | ISO | RGD:731404 | 6480464 | lactacystin inhibits the reaction [Deoxycholic Acid results in increased expression of PRKCB protein] | CTD | PMID:17644113 |
| lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of PRKCB protein | CTD | PMID:16547843 |
| lead(0) | decreases expression | EXP | | 6480464 | Lead results in decreased expression of PRKCB protein | CTD | PMID:16547843 |
| losartan | multiple interactions | EXP | | 6480464 | Losartan inhibits the reaction [Ethanol results in increased expression of PRKCB protein] | CTD | PMID:22497828 |
| metformin | decreases expression | ISO | RGD:731404 | 6480464 | Metformin results in decreased expression of PRKCB mRNA; more ... | CTD | PMID:15531508 |
| methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of PRKCB mRNA | CTD | PMID:15120968 |
| methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of PRKCB mRNA | CTD | PMID:15120968 |
| morphine | multiple interactions | ISO | RGD:1550017 | 6480464 | Morphine promotes the reaction [OPRM1 protein binds to PRKCB protein]; more ... | CTD | PMID:18652891 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1550017 | 6480464 | Diethylnitrosamine results in increased phosphorylation of and results in increased activity of PRKCB protein; more ... | CTD | PMID:17942915 |
| paracetamol | affects expression | ISO | RGD:1550017 | 6480464 | Acetaminophen affects the expression of PRKCB mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:731404 | 6480464 | Acetaminophen results in increased expression of PRKCB mRNA | CTD | PMID:21420995 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of PRKCB mRNA | CTD | PMID:15120968 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of PRKCB mRNA | CTD | PMID:19162173 |
| phenylephrine | multiple interactions | EXP | | 6480464 | Phenylephrine promotes the reaction [RBCK1 protein binds to PRKCB protein]; more ... | CTD | PMID:17121852 |
| phenylephrine | increases expression | EXP | | 6480464 | Phenylephrine results in increased expression of PRKCB protein | CTD | PMID:17121852 |
| phorbol 13-acetate 12-myristate | affects localization | ISO | RGD:731404 | 6480464 | Tetradecanoylphorbol Acetate affects the localization of PRKCB protein | CTD | PMID:15976015 |
| phorbol 13-acetate 12-myristate | affects localization | ISO | RGD:731404 | 6480464 | Tetradecanoylphorbol Acetate affects the localization of PRKCB protein | CTD | PMID:15976015 PMID:19447859 |
| phorbol 13-acetate 12-myristate | decreases expression | ISO | RGD:731404 | 6480464 | Tetradecanoylphorbol Acetate results in decreased expression of PRKCB protein modified form | CTD | PMID:15330761 |
| phorbol 13-acetate 12-myristate | affects localization | ISO | RGD:731404 | 6480464 | Tetradecanoylphorbol Acetate affects the localization of PRKCB protein alternative form | CTD | PMID:21705328 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:731404 | 6480464 | PRKCB protein alternative form affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] | CTD | PMID:21705328 |
| phorbol 13-acetate 12-myristate | increases activity | ISO | RGD:1550017 | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of PRKCB protein | CTD | PMID:1724372 |
| phorbol 13-acetate 12-myristate | decreases phosphorylation | ISO | RGD:731404 | 6480464 | Tetradecanoylphorbol Acetate results in decreased phosphorylation of PRKCB protein | CTD | PMID:15380616 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:731404 | 6480464 | PRKCB protein affects the reaction [Tetradecanoylphorbol Acetate affects the localization of Zinc] | CTD | PMID:16495082 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:731404 | 6480464 | [Ethanol results in increased localization of and results in increased activity of PRKCB protein] promotes the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Superoxides] | CTD | PMID:10651808 |
| pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of PRKCB mRNA | CTD | PMID:19162173 |
| pterostilbene | multiple interactions | ISO | RGD:1550017 | 6480464 | pterostilbene inhibits the reaction [Azoxymethane results in increased phosphorylation of and results in increased activity of PRKCB protein] | CTD | PMID:21355597 |
| resveratrol | multiple interactions | ISO | RGD:731404 | 6480464 | resveratrol inhibits the reaction [Glucose results in increased activity of PRKCB protein] | CTD | PMID:20578705 |
| rosiglitazone | affects response to substance | ISO | RGD:1550017 | 6480464 | PRKCB protein affects the susceptibility to rosiglitazone | CTD | PMID:16672634 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | decreases activity | EXP | | 6480464 | Buthionine Sulfoximine results in decreased activity of PRKCB protein | CTD | PMID:11118818 |
| selenium atom | decreases expression | ISO | RGD:731404 | 6480464 | Selenium results in decreased expression of PRKCB mRNA | CTD | PMID:19244175 |
| streptozocin | increases phosphorylation | EXP | | 6480464 | Streptozocin results in increased phosphorylation of PRKCB protein | CTD | PMID:16980342 |
| superoxide | multiple interactions | ISO | RGD:731404 | 6480464 | [Ethanol results in increased localization of and results in increased activity of PRKCB protein] promotes the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Superoxides] | CTD | PMID:10651808 |
| tamibarotene | increases expression | ISO | RGD:731404 | 6480464 | Am 80 results in increased expression of PRKCB mRNA; more ... | CTD | PMID:15498508 |
| tetrodotoxin | multiple interactions | EXP | | 6480464 | [Bupivacaine co-treated with Tetrodotoxin co-treated with Dexamethasone] results in decreased expression of PRKCB mRNA | CTD | PMID:22341215 |
| thapsigargin | multiple interactions | ISO | RGD:731404 | 6480464 | Thapsigargin inhibits the reaction [EGF protein affects the localization of PRKCB protein] | CTD | PMID:17991733 |
| thiabendazole | increases expression | EXP | | 6480464 | Thiabendazole results in increased expression of PRKCB mRNA | CTD | PMID:18539377 |
| thiram | decreases activity | ISO | RGD:731404 | 6480464 | Thiram results in decreased activity of PRKCB protein | CTD | PMID:15998240 |
| toluene | affects expression | EXP | | 6480464 | Toluene affects the expression of PRKCB mRNA | CTD | PMID:21827849 |
| trans-resveratrol | multiple interactions | ISO | RGD:731404 | 6480464 | resveratrol inhibits the reaction [Glucose results in increased activity of PRKCB protein] | CTD | PMID:20578705 |
| vanadium atom | decreases expression | ISO | RGD:731404 | 6480464 | Vanadium results in decreased expression of PRKCB mRNA | CTD | PMID:19000753 |
| vanadium(0) | decreases expression | ISO | RGD:731404 | 6480464 | Vanadium results in decreased expression of PRKCB mRNA | CTD | PMID:19000753 |
| zinc atom | multiple interactions | ISO | RGD:1550017 | 6480464 | Zinc promotes the reaction [FCER1A protein affects the localization of PRKCB protein] | CTD | PMID:16818790 |
| zinc atom | multiple interactions | ISO | RGD:1550017 | 6480464 | Zinc promotes the reaction [OPRM1 protein binds to PRKCB protein] | CTD | PMID:18652891 |
| zinc atom | multiple interactions | ISO | RGD:731404 | 6480464 | PRKCB protein affects the reaction [Tetradecanoylphorbol Acetate affects the localization of Zinc] | CTD | PMID:16495082 |
| zinc(0) | multiple interactions | ISO | RGD:1550017 | 6480464 | Zinc promotes the reaction [FCER1A protein affects the localization of PRKCB protein] | CTD | PMID:16818790 |
| zinc(0) | multiple interactions | ISO | RGD:731404 | 6480464 | PRKCB protein affects the reaction [Tetradecanoylphorbol Acetate affects the localization of Zinc] | CTD | PMID:16495082 |
| zinc(0) | multiple interactions | ISO | RGD:1550017 | 6480464 | Zinc promotes the reaction [OPRM1 protein binds to PRKCB protein] | CTD | PMID:18652891 |